The NAI Fellows Program recognizes academic inventors whose discoveries are translated into technologies that benefit society. Nolte's work in biophotonics and optical imaging has resulted in 20+ Purdue patents, 50+ patent applications, and the founding of two Purdue-based startup companies. https://t.co/dnNbGSGB2q
A new multicenter clinical utility study is evaluating how the PanCystPro assay may help guide care decisions for patients with pancreatic cystic lesions, which are known precursors to pancreatic cancer.
The technology was developed by Purdue researcher and PICR member V. Jo Davisson and commercialized through Amplified Sciences. https://t.co/zq1gcD2QfJ
@PurdueInnovates | @purduepharmacy
.@AmpSciences, a diagnostics life sciences company revolutionizing early disease detection, announced Friday, May 8 the launch of PanAMP, a clinical utility study for its PanCystPro assay.
Read more: https://t.co/8zI0IrxS7N
Congratulation to Novin AgriTech, a startup that licenses @LifeAtPurdue IP from the Office of Technology Commercialization.
It has received an $175K SBIR grant from the @USDA: https://t.co/CIwuFkKyxZ
Purdue Innovates Incubator awarded $50,000 to four teams of @LifeAtPurdue student entrepreneurs during the annual New Venture Challenge last week!
Read more: https://t.co/0RlsPl34Dz
🚀 AI is everywhere. Production-ready AI is where things get real.
Six Feet Up CTO @calvinhp joins @lolavisionsys CEO Tayo Adesanya on the @PurdueInnovates panel, “Commercializing AI.” 🤖
👉Infrastructure, data readiness & hardware/software convergence https://t.co/EWMv5lGpQq
.@LifeAtPurdue is becoming "The Semiconductor University," and several Purdue Engineering professors are at the helm.
On the three-year anniversary of the Purdue Computes initiative, read more about the campus-wide push involving @PurdueECE, @PurdueME and other units: https://t.co/yI6cGgeCFT
Congratulations to @helpwithleto, an Indiana startup and public benefit corporation, for launching its software system that allows users to more efficiently connect their clients with community resources.
Read more: https://t.co/qwO0DM0oFt
When you use an AI photo editor, you're uploading your face to a cloud platform and losing control of your biometric data.
More about a patent-pending fix by @purdue_ie and @PurdueECE researchers, published in @IEEEorg Transactions on Artificial Intelligence: https://t.co/CamWte1MBG
@PurdueInnovates
Can you dig it? @PurdueCCE and @PurdueInnovates radar technology could decrease hazardous strikes to underground utility pipes during construction projects.
How the patent-pending tech could lower related financial losses, service disruptions, injuries and fatalities: https://t.co/7QslpPcWm6
The Purdue Quantum Code Library can inexpensively and quickly model semiconductors that are ultrasmall yet high performing and resilient.
How electronics manufacturers could benefit: https://t.co/TT2uyPEzGm
@PurdueECE | @PurdueInnovates
A patent-pending tool from @LifeAtPurdue to stop AI from exposing private identities during photo editing and sharing is available for licensing and commercializing.
Read more: https://t.co/gZ4jCgP3Sg
@PurdueEngineers@PurdueScience | @PurdueCS
Congratulations to Wavelogix, which licenses @LifeAtPurdue concrete sensor innovations through the Purdue Innovates Office of Technology Commercialization.
The company has received a $500,000 SBIR Phase IIB grant from @NSF: https://t.co/HfVK7T7V92
@PurdueEngineers | @PurdueCCE
A patent-pending @LifeAtPurdue 3D object detection system dynamically adjusts detection strategies based on real-time hardware constraints.
AGILE3D is available for licensing and commercialization: https://t.co/Jdp2BPKD8a
@PurdueEngineers | @PurdueAg | @PurdueABE
Purdue University mourns the loss of Phil Low, drug discovery scholar and decorated innovator, who died Wednesday (March 4) at the age of 78. https://t.co/ijli03WzMi
A new @LifeAtPurdue vaccine that could address wild animal overpopulation is available for development and commercialization.
Read more: https://t.co/F6KTu9GmvP
#Wildlife#Overpopulation#Vaccine
Electronics manufacturers can get nonexclusive licenses for @LifeAtPurdue’s Quantum Code Library, which models semiconductors as small as 2-3 nm.
Read more: https://t.co/wNBcCKVu52
#Code#Modeling#Semiconductors
.@AmpSciences, which licenses @purduepharmacy innovations, has reached a new milestone for the commercial scaling of its lead assay for pancreatic cancer risk stratification.
Read more: https://t.co/gJVsgj8r1B
A drug first developed at Purdue is moving forward in the fight against glioblastoma.
Gibson Oncology + NIH have launched a Phase 2 trial of LMP744 for first-time recurrent glioblastoma.
Originally designed at Purdue by a research group led by PICR member emeritus Mark Cushman, the drug targets topo 1 + cMYC.
~40 patients will be enrolled. https://t.co/vbFWR0GMif